Patents by Inventor Jeffrey Schultchen

Jeffrey Schultchen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250082696
    Abstract: The present invention relates to a composition comprising one or more fructanases and one or more Lactobacillus strains to provide relief from or prevent fructan and/or fructose induced abdominal discomfort; digest fructan and/or fructose or improve digestion of fructan and/or fructose; and/or provide digestive comfort after digestion of fructan and/or fructose on consumption of products containing fructan and/or fructose to a subject. The present invention also relates a Lactobacillus strain or a fructanse for providing relief from fructan and/or fructose induced abdominal discomfort to a subject, wherein the Lactobacillus strain in presence of one or more fructanases results in at least 20-50% reduction of gas pressure development, when tested against the fecal fermentation of the fiber alone across different donors.
    Type: Application
    Filed: January 6, 2023
    Publication date: March 13, 2025
    Applicant: Novozymes A/S
    Inventors: Kristian Bertel Romer M. KROGH, Jeffrey SCHULTCHEN, Lea Benedicte Skov HANSEN, Sameer KULKARNI, Jason QUINLAN
  • Patent number: 11963986
    Abstract: The application discloses Lactobacillus strains having a beneficial effect on the metabolic health on a mammalian subject. Further disclosed is compositions comprising such strains and the use thereof for improving the metabolic health or for lowering the blood glucose level in a mammalian subject.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: April 23, 2024
    Assignee: Novozymes A/S
    Inventors: Nanna Ny Kristensen, Alexandra Mattern, Delphine Marie Anne Saulnier, Jeffrey Schultchen, Teis Jensen, Benjamin Anderschou Holbech Jensen
  • Publication number: 20210393712
    Abstract: The application discloses Lactobacillus strains having a beneficial effect on the metabolic health on a mammalian subject. Further disclosed is compositions comprising such strains and the use thereof for improving the metabolic health or for lowering the blood glucose level in a mammalian subject.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 23, 2021
    Applicant: Novozymes A/S
    Inventors: Nanna Ny Kristensen, Alexandra Mattern, Delphine Marie Anne Saulnier, Jeffrey Schultchen, Teis Jensen, Benjamin Anderschou Holbech Jensen